SHARK MONEYYACHT CLUBSearch Shark Money
Search public and private companies, people, funds, markets, tools, and research.
Venture capital database
Company origination · Venture creation · Long-term growth support
Flagship Pioneering
Cambridge, Massachusetts, US
Flagship Pioneering focuses on Human health, Climate & Energy, Artificial intelligence, Biotechnology across company origination through venture creation through long-term growth support. Team and company relationships are indexed from official firm pages.
Strategy lens
Declared focus vs. observed sample
Declared focus reflects the firm’s own strategy language. Observed sectors summarize only the source-linked companies currently indexed here; it is not the firm’s complete portfolio allocation.
agricultural biotechnology1
cell-centric drug discovery1
chromatin biology therapeutics1
gene-writing therapeutics1
mRNA medicines1
protein therapeutics / generative biology1
Founder fit screen
Prepare before contacting Flagship
Use the firm’s declared strategy and sourced relationship graph to build a specific outreach thesis. This is a preparation framework—not a claim about current appetite or check size.
Stage fit
Explain why the company belongs in Company origination, Venture creation, Long-term growth support and what proof has already removed the prior stage’s risk.
Sector fit
Anchor the opportunity to Human health, Climate & Energy, Artificial intelligence. Name the specific market shift and why it is happening now.
Partner fit
Review 2 indexed team profiles. Address the partner whose operating history and portfolio context best match the company.
Portfolio context
Study the 6 source-linked companies shown here. State whether the company is complementary, differentiated, or potentially competitive.
Evidence packet
Bring customer proof, cohort or deployment metrics, gross-margin logic, capital use, key risks, and the milestone this financing should unlock.
Contact route
Use the firm’s public route and keep the request precise: company, stage, round, traction, why this firm, and one clear next step.
Key people
Official team source Who shapes the partnership
Founder & CEO
Noubar Afeyan
Founder & CEO at Flagship Pioneering, working in a firm focused on Human health, Climate & Energy, Artificial intelligence, Biotechnology.
Managing Partner
Stephen Berenson
Managing Partner at Flagship Pioneering, working in a firm focused on Human health, Climate & Energy, Artificial intelligence, Biotechnology. Selected relationships
Official portfolio source Investments listed by the firm
cell-centric drug discovery
Official sourceCellarity
Open the company graph to see founders and every indexed investor relationship.
chromatin biology therapeutics
Official sourceFoghorn Therapeutics
Open the company graph to see founders and every indexed investor relationship.
protein therapeutics / generative biology
Official sourceGenerate:Biomedicines
Open the company graph to see founders and every indexed investor relationship.
agricultural biotechnology
Official sourceInari
Open the company graph to see founders and every indexed investor relationship.
mRNA medicines
Official sourceModerna
Open the company graph to see founders and every indexed investor relationship.
gene-writing therapeutics
Official sourceTessera Therapeutics
Open the company graph to see founders and every indexed investor relationship.
Co-investment map
Firms sharing listed companies
Ranked by shared companies in this indexed dataset—not necessarily the same financing round.
Help complete the graphClaim or improve
Claim or improve
Flagship Pioneering.
Founders, firm teams, investors, and careful researchers can submit a missing fact or correction. Every change enters a review queue and requires public evidence.
- No unsourced edits
- Identity and scope reviewed
- Existing claims retain history
Source discipline
This dossier uses publicly available firm pages for team, strategy, and portfolio context. It does not infer check size, ownership, valuation, current holding status, or availability for introductions.